oxaceprol

Known as: 1-acetyl-4-hydroxy-L- proline, N-acetyl-4-hydroxyproline, N-acetylhydroxyproline 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2011
01219872011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
OBJECTIVE To evaluate efficacy of therapy with oxaceprol in the treatment of symptomatic osteoarthritis of knee or hip. METHODS… (More)
Is this relevant?
2003
2003
The HIMAGE study, conducted in partnership with the principal Public Health Insurance Funds of the Loire region, analysed… (More)
Is this relevant?
2002
2002
The aim of this meta-analysis based on the literature was to gather all evidence of randomized clinical trials to assess the… (More)
Is this relevant?
2001
2001
Oxaceprol (N-acetyl-L-hydroxyproline), an atypical inhibitor of inflammation, is an established drug forjoint disease without… (More)
Is this relevant?
2000
2000
The therapeutic equivalence and safety of treatment for 21 days with 400 mg t.i.d. oxaceprol (n= 132) and 50 mg t.i.d. diclofenac… (More)
  • table 2
  • table 1
  • figure 1
  • table 3
  • table 4
Is this relevant?
1999
1999
In this multicentre (five centres in Germany), randomised, double-blind, comparative study, 150 patients with painful… (More)
  • figure 2
  • table 1
  • figure 3
  • figure 1
  • figure 4
Is this relevant?
Review
1999
Review
1999
Most anti-inflammatory agents used in the treatment of joint diseases exert inhibitory effects on leukocyte infiltration… (More)
Is this relevant?
1998
1998
Oxaceprol, an established drug for treatment of degenerative joint disease, has recently been shown in vitro to reduce leukocyte… (More)
Is this relevant?
1996
1996
Oxaceprol, an established therapeutic agent for osteoarthritis, had no effect on macrophage prostaglandin E2 release in vitro and… (More)
Is this relevant?
1990
1990
Blood and plasma levels and renal and faecal excretion of 14C-oxaceprol (N-acetyl-4-hydroxyproline, AHP 200) were measured after… (More)
Is this relevant?